Medical Design and Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Contract Manufacturing
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • Med Tech Resources
    • Subscribe to Print Magazine
    • DeviceTalks Tuesdays
    • Digital Editions
    • eBooks
    • Manufacturer Search
    • Medical Device Handbook
    • MedTech 100 Index
    • Podcasts
    • Print Subscription
    • The Big 100
    • Webinars / Digital Events
    • Whitepapers
    • Video
  • 2022 Leadership in MedTech
    • 2022 Leadership Voting!
    • 2021 Winners
    • 2020 Winners
  • Women in Medtech

German High Court Rules in Favor of AmniSure® as New European Guidelines Published

March 4, 2011 By Bio-Medicine.Org

KARLSRUHE, Germany, March 4, 2011 /PRNewswire/ — The High Court
of Germany (Bundesgerichtshof) handed down a final ruling in
favor of AmniSure® International, LLC in its dispute with the
Finnish company Medix Biochemica. The court upheld the German
Patent Court’s ruling that the patent associated with Medix’s
ActimPROM test is null and void due to its lack of an inventive
step. Medix is expected to pay AmniSure® an undisclosed amount
to be determined by the courts.

“We are extremely pleased with the decision of the German High
Court,” said Dr. Michael Friedman, President and CEO of
AmniSure® International. “The Court’s decision coincided with
the publication of the new peer-reviewed Guidelines of the European
Association of Perinatal Medicine, which hailed the AmniSure®
test as the ‘most useful tool’ and the ‘most accurate bedside test’
for diagnosing ruptured fetal membranes(1). The Court’s decision
closes a chapter for us by bringing a seven-year-long litigation,
initiated by Medix, to its rightful conclusion. The publication of
the European Guidelines, meanwhile, opens a new chapter for us by
establishing the AmniSure® test as the new benchmark for
diagnosing ruptured fetal membranes.”

(1) The Journal of Maternal-Fetal and Neonatal Medicine, March
2011. ISSN 1476-7058

About AmniSure® International, LLCAmniSure®
International, LLC (http://www.amnisure.com) is a
medical device company that operates internationally with
headquarters in Boston, MA. AmniSure® International pioneered a
rapid diagnostic device, AmniSure® ROM Test, which solves a
long-standing problem in obstetrics and is rapidly becoming a new
global standard in maternal fetal medicine. Contact:
info@amnisure.com
 617-234-4441 Tel.This press release was
issued through eReleases(R).  For more information, visit
eReleases

SOURCE

Related Articles Read More >

TE Connectivity opens global medical device prototyping center in Ireland
Prix Galien USA 2022 nominees
The 24 best medical device innovations of 2022
A portrait of Ellen Roche, MIT School of Engineering associate professor
New implant design prevents scar tissue without drugs, MIT says
UMN artificial blood vessel clinical trial
Minnesota researchers awarded $3.7M grant for artificial, bioengineered blood vessel clinical trial

DeviceTalks Weekly.

August 12, 2022
DTW – Medtronic’s Mauri brings years of patient care to top clinical, regulatory, scientific post
See More >

MDO Digital Edition

Digital Edition

Subscribe to Medical Design & Outsourcing. Bookmark, share and interact with the leading medical design engineering magazine today.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
DeviceTalks

DeviceTalks is a conversation among medical technology leaders. It's events, podcasts, webinars and one-on-one exchanges of ideas & insights.

DeviceTalks

New MedTech Resource

Medical Tubing

Enewsletter Subscriptions

Enewsletter Subscriptions

MassDevice

Mass Device

The Medical Device Business Journal. MassDevice is the leading medical device news business journal telling the stories of the devices that save lives.

Visit Website
MDO ad
Medical Design and Outsourcing
  • MassDevice
  • DeviceTalks
  • MedTech100 Index
  • Medical Tubing + Extrusion
  • Medical Design Sourcing
  • Drug Delivery Business News
  • Drug Discovery & Development
  • Pharmaceutical Processing World
  • R&D World
  • About Us/Contact
  • Advertise With Us
  • Subscribe to Print Magazine
  • Subscribe to E-newsletter
  • Attend our Monthly Webinars
  • Listen to our Weekly Podcasts
  • Join our DeviceTalks Tuesdays Discussion

Copyright © 2022 WTWH Media, LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media LLC. Site Map | Privacy Policy | RSS

Search Medical Design & Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Contract Manufacturing
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • Med Tech Resources
    • Subscribe to Print Magazine
    • DeviceTalks Tuesdays
    • Digital Editions
    • eBooks
    • Manufacturer Search
    • Medical Device Handbook
    • MedTech 100 Index
    • Podcasts
    • Print Subscription
    • The Big 100
    • Webinars / Digital Events
    • Whitepapers
    • Video
  • 2022 Leadership in MedTech
    • 2022 Leadership Voting!
    • 2021 Winners
    • 2020 Winners
  • Women in Medtech